<SEC-DOCUMENT>0001764013-26-000093-index.html : 20260722
<SEC-HEADER>0001764013-26-000093.hdr.sgml : 20260722
<ACCEPTANCE-DATETIME>20260722161320
ACCESSION NUMBER:		0001764013-26-000093
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20260722
DATE AS OF CHANGE:		20260722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunovant, Inc.
		CENTRAL INDEX KEY:			0001764013
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				832771572
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38906
		FILM NUMBER:		261193829

	BUSINESS ADDRESS:	
		STREET 1:		1000 PARK FORTY PLAZA
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27713
		BUSINESS PHONE:		917-410-3120

	MAIL ADDRESS:	
		STREET 1:		1000 PARK FORTY PLAZA
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27713

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
		DATE OF NAME CHANGE:	20190108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14aadditionalmaterials.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: defa14aadditionalmaterials.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>immunovantinc_vxnoticeanda.jpg
<TEXT>
Document 2 - file: immunovantinc_vxnoticeanda.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>immunovantinc_vxnoticeandaa.jpg
<TEXT>
Document 3 - file: immunovantinc_vxnoticeandaa.jpg

</DOCUMENT>
</SEC-DOCUMENT>